BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15879414)

  • 1. A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population.
    van Diemen CC; Postma DS; Vonk JM; Bruinenberg M; Schouten JP; Boezen HM
    Am J Respir Crit Care Med; 2005 Aug; 172(3):329-33. PubMed ID: 15879414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology.
    Gosman MM; Boezen HM; van Diemen CC; Snoeck-Stroband JB; Lapperre TS; Hiemstra PS; Ten Hacken NH; Stolk J; Postma DS
    Thorax; 2007 Mar; 62(3):242-7. PubMed ID: 17090574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decorin and TGF-beta1 polymorphisms and development of COPD in a general population.
    van Diemen CC; Postma DS; Vonk JM; Bruinenberg M; Nolte IM; Boezen HM
    Respir Res; 2006 Jun; 7(1):89. PubMed ID: 16780585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel strategy to identify genetic risk factors for COPD severity: a genetic isolate.
    van Diemen CC; Postma DS; Aulchenko YS; Snijders PJ; Oostra BA; van Duijn CM; Boezen HM
    Eur Respir J; 2010 Apr; 35(4):768-75. PubMed ID: 19797132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in a disintegrin and metalloprotease 33 (ADAM33) predict impaired early-life lung function.
    Simpson A; Maniatis N; Jury F; Cakebread JA; Lowe LA; Holgate ST; Woodcock A; Ollier WE; Collins A; Custovic A; Holloway JW; John SL
    Am J Respir Crit Care Med; 2005 Jul; 172(1):55-60. PubMed ID: 15805180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superoxide dismutases, lung function and bronchial responsiveness in a general population.
    Siedlinski M; van Diemen CC; Postma DS; Vonk JM; Boezen HM
    Eur Respir J; 2009 May; 33(5):986-92. PubMed ID: 19213780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of the ADAM33 gene are associated with accelerated lung function decline in asthma.
    Jongepier H; Boezen HM; Dijkstra A; Howard TD; Vonk JM; Koppelman GH; Zheng SL; Meyers DA; Bleecker ER; Postma DS
    Clin Exp Allergy; 2004 May; 34(5):757-60. PubMed ID: 15144468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAM33 polymorphism: association with bronchial hyper-responsiveness in Korean asthmatics.
    Lee JH; Park HS; Park SW; Jang AS; Uh ST; Rhim T; Park CS; Hong SJ; Holgate ST; Holloway JW; Shin HD
    Clin Exp Allergy; 2004 Jun; 34(6):860-5. PubMed ID: 15196271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoke exposure interacts with ADAM33 polymorphisms in the development of lung function and hyperresponsiveness.
    Reijmerink NE; Kerkhof M; Koppelman GH; Gerritsen J; de Jongste JC; Smit HA; Brunekreef B; Postma DS
    Allergy; 2009 Jun; 64(6):898-904. PubMed ID: 19236319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung function loss, smoking, vitamin C intake, and polymorphisms of the glutamate-cysteine ligase genes.
    Siedlinski M; Postma DS; van Diemen CC; Blokstra A; Smit HA; Boezen HM
    Am J Respir Crit Care Med; 2008 Jul; 178(1):13-9. PubMed ID: 18420959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of polymorphisms in ADAM33, a disintegrin and metalloprotease 33, in childhood asthma and lung function in two German populations.
    Schedel M; Depner M; Schoen C; Weiland SK; Vogelberg C; Niggemann B; Lau S; Illig T; Klopp N; Wahn U; von Mutius E; Nickel R; Kabesch M
    Respir Res; 2006 Jun; 7(1):91. PubMed ID: 16784537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAM33 polymorphisms and phenotype associations in childhood asthma.
    Raby BA; Silverman EK; Kwiatkowski DJ; Lange C; Lazarus R; Weiss ST
    J Allergy Clin Immunol; 2004 Jun; 113(6):1071-8. PubMed ID: 15208587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of ADAM33 gene polymorphisms with COPD in the Mongolian population of China.
    Tan J; Liu AP; Sun C; Bai YF; Lv F
    Ann Hum Biol; 2014; 41(1):9-14. PubMed ID: 24191661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decline in FEV1 related to genetic polymorphisms (+138insA/delA and Lys198Asn) of the endothelin-1 gene in COPD. A pilot study.
    Kaparianos A; Argyropoulou E; Efremidis G; Flordellis C; Spiropoulos K
    Eur Rev Med Pharmacol Sci; 2010 Aug; 14(8):705-19. PubMed ID: 20707291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in ADAM33 are associated with allergic rhinitis due to Japanese cedar pollen.
    Cheng L; Enomoto T; Hirota T; Shimizu M; Takahashi N; Akahoshi M; Matsuda A; Dake Y; Doi S; Enomoto K; Yamasaki A; Fukuda S; Mao XQ; Hopkin JM; Tamari M; Shirakawa T
    Clin Exp Allergy; 2004 Aug; 34(8):1192-201. PubMed ID: 15298558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD.
    Bridevaux PO; Gerbase MW; Probst-Hensch NM; Schindler C; Gaspoz JM; Rochat T
    Thorax; 2008 Sep; 63(9):768-74. PubMed ID: 18505800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADAM33 polymorphisms are associated with asthma susceptibility in a Japanese population.
    Noguchi E; Ohtsuki Y; Tokunaga K; Yamaoka-Sageshima M; Ichikawa K; Aoki T; Shibasaki M; Arinami T
    Clin Exp Allergy; 2006 May; 36(5):602-8. PubMed ID: 16650044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of polymorphisms in the β2-adrenergic receptor on the susceptibility and pulmonary function of patients with chronic obstructive pulmonary disease: a meta analysis.
    Niu LM; Liang Y; Xu M; Zhang YY; Zhang Y; He B
    Chin Med J (Engl); 2012 Jun; 125(12):2213-8. PubMed ID: 22884155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study.
    Garcia-Aymerich J; Lange P; Benet M; Schnohr P; Antó JM
    Am J Respir Crit Care Med; 2007 Mar; 175(5):458-63. PubMed ID: 17158282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL13 promoter polymorphism 1112C/T modulates the adverse effect of tobacco smoking on lung function.
    Sadeghnejad A; Meyers DA; Bottai M; Sterling DA; Bleecker ER; Ohar JA
    Am J Respir Crit Care Med; 2007 Oct; 176(8):748-52. PubMed ID: 17615386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.